Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Targeting TGF–β for treatment of disease

Nature Medicine volume 1, pages 1000–1001 (1995)Cite this article

A new study suggests that stimulating TGF-β production protects against atherosclerosis (1067–1073). But other studies have shown that TGF-β overproduction can cause tissue fibrosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Grainger, D.J., Witchell, C.M. & Metcalfe, J.C. Tamoxifen elevates transforming growth factor-β and suppresses diet-induced formation of lipid lesions in mouse aorta. Nature Med. 1, 1067–1073. (1995).

    Article  CAS  Google Scholar 

  2. Sporn, M.B. & Roberts, A.B. A major advance in the use of growth factors to enhance wound healing. J. clin. Invest. 92, 2565–2566. (1993).

    Article  CAS  Google Scholar 

  3. Beck, L.S. et al. One systemic administration of transforming growth factor-β1 reverses age- or glucocorticoid-impaired wound healing. J. clin. Invest 92, 2841–2849. (1993).

    Article  CAS  Google Scholar 

  4. Wahl, S.M. Transforming growth factor β: The good, the bad, and the ugly. J. exp. Med. 180, 1587–1590. (1994).

    Article  CAS  Google Scholar 

  5. Border, W.A. & Noble, N.A. Transforming growth factor β in tissue fibrosis. New Engl. J. Med. 331, 1286–1292. (1994).

    Article  CAS  Google Scholar 

  6. Kadin, M.E. et al. Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc. natn. Acad. Sd. U.SA. 92, 6002–6006. (1994).

    Article  Google Scholar 

  7. Markowitz, S. et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336–1338. (1995).

    Article  CAS  Google Scholar 

  8. Kojima, S., Harpel, P.C. & Rifkin, D.B. Lipoprotein (a) inhibits the generation of transforming growth factor β: An endogenous inhibitor of smooth muscle cell migration. J. Cell Biol. 113, 1439–1445. (1991).

    Article  CAS  Google Scholar 

  9. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801–809. (1993).

    Article  CAS  Google Scholar 

  10. Grainger, D.J. et al. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nature Med. 1, 74–79. (1995).

    Article  CAS  Google Scholar 

  11. Dickson, K., Philip, A., Warshawsky, H., O'Connor-McCourt, M. & Bergeron, J.J.M. Specific binding of endocrine transforming growth factor-βl to vascular endothelium. J. clin. Invest. 95, 2539–2554. (1995).

    Article  CAS  Google Scholar 

  12. Nikol, S. et al. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J. clin. Invest. 90, 1582–1592. (1992).

    Article  CAS  Google Scholar 

  13. Wolf, Y.G., Rasmussen, L.M. & Ruoslahti, E. Antibodies against transforming growth factor-βl suppress intimal hyperplasia in a rat model. J. clin. Invest. 93, 1172–1178. (1994).

    Article  CAS  Google Scholar 

  14. Nabel, E.G. et al. Direct transfer of transforming growth factor β1 gene into arteries stimulates fi-brocellular hyperplasia. Proc. natn. Acad. Sd. U.SA. 90, 10759–10763. (1993).

    Article  CAS  Google Scholar 

  15. Zugmaier, G. et al. Transforming growth factor β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res. 51, 3590–3594. (1991).

    CAS  PubMed  Google Scholar 

  16. Anscher, M.S. et al. Transforming growth factor β as a predictor of liver and lung fibrosis after au-tologous bone marrow transplantation for advanced breast cancer. New Engl. J. Med. 328, 1592–1598. (1993).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, University of Utah School of Medicine, Salt Lake City, Utah, 84132, USA

    Wayne A. Border & Nancy A. Noble

Authors
  1. Wayne A. Border
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy A. Noble
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Border, W., Noble, N. Targeting TGF–β for treatment of disease. Nat Med 1, 1000–1001 (1995). https://doi.org/10.1038/nm1095-1000

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1095-1000

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing